Advantage Alpha Capital Partners LP Purchases New Stake in Omnicell, Inc. $OMCL

Advantage Alpha Capital Partners LP acquired a new position in shares of Omnicell, Inc. (NASDAQ:OMCL) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 84,217 shares of the company’s stock, valued at approximately $2,476,000. Advantage Alpha Capital Partners LP owned approximately 0.18% of Omnicell as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently added to or reduced their stakes in OMCL. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Omnicell during the 1st quarter worth $2,073,000. GSA Capital Partners LLP purchased a new stake in shares of Omnicell in the first quarter valued at about $901,000. XTX Topco Ltd increased its position in Omnicell by 316.1% during the first quarter. XTX Topco Ltd now owns 30,295 shares of the company’s stock worth $1,059,000 after purchasing an additional 23,015 shares during the last quarter. Arkadios Wealth Advisors increased its position in Omnicell by 7.5% during the first quarter. Arkadios Wealth Advisors now owns 46,705 shares of the company’s stock worth $1,633,000 after purchasing an additional 3,251 shares during the last quarter. Finally, New Age Alpha Advisors LLC purchased a new position in Omnicell during the first quarter worth about $233,000. 97.70% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Omnicell

In other news, EVP Corey J. Manley sold 3,880 shares of the firm’s stock in a transaction on Friday, September 12th. The stock was sold at an average price of $33.25, for a total transaction of $129,010.00. Following the completion of the transaction, the executive vice president directly owned 110,653 shares in the company, valued at $3,679,212.25. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 2.52% of the stock is currently owned by corporate insiders.

Omnicell Stock Performance

Shares of OMCL stock opened at $36.66 on Friday. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.24 and a current ratio of 1.42. The firm has a market cap of $1.65 billion, a P/E ratio of 73.32, a P/E/G ratio of 6.29 and a beta of 0.95. The firm’s 50 day moving average price is $32.55 and its 200-day moving average price is $30.98. Omnicell, Inc. has a one year low of $22.66 and a one year high of $48.67.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on OMCL shares. Wall Street Zen cut shares of Omnicell from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Benchmark lifted their price target on shares of Omnicell from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Piper Sandler lowered their price objective on Omnicell from $57.00 to $55.00 and set an “overweight” rating for the company in a research report on Monday, August 11th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of Omnicell in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Omnicell has a consensus rating of “Hold” and an average price target of $42.00.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.